Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_assertion type Assertion NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_head.
- NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_assertion description "[Overexpression of high-mobility group A2 was observed in 39% (38/98) of pituitary adenomas compared with normal adenohypophysial tissue and was frequently found in adenomas including prolactin (PRL), adrenocorticotrophic hormone, or follicle-stimulating hormone/luteinizing hormone and in null cell adenomas, but relatively rare in growth hormone (GH) and mixed GH/PRL adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_provenance.
- NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_assertion evidence source_evidence_literature NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_provenance.
- NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_assertion SIO_000772 19136928 NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_provenance.
- NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_assertion wasDerivedFrom befree-2016 NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_provenance.
- NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_assertion wasGeneratedBy ECO_0000203 NP713405.RAC8l6xJoruE3mz06xsh9QklhvmqyHt_NR1TlrRz-qldg130_provenance.